<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2317">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01567839</url>
  </required_header>
  <id_info>
    <org_study_id>4% dental local anesthetics</org_study_id>
    <nct_id>NCT01567839</nct_id>
  </id_info>
  <brief_title>Testing the Anesthetic Effectiveness of Three Different Dental Local Anesthetics Injected Next to a Lower First Molar</brief_title>
  <official_title>Anesthetic Efficacy of 4% Articaine With 1:100,000 Epinephrine, 4% Prilocaine With 1:200,000 Epinephrine, and 4% Lidocaine With 1:100,000 Epinephrine as a Primary Buccal Infiltration in the Mandibular First Molar.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infiltration (injecting next to the tooth) injections are common in dentistry and a number
      of studies have shown that articaine anesthetic, when injected next to the tooth as a
      supplemental injection, works very well following a typical inferior alveolar (lower jaw)
      nerve block. No study has compared 4% articaine with 1:100,000 epinephrine, 4% prilocaine
      with 1:200,000 epinephrine, and 4% lidocaine with 1:100,000 epinephrine in mandibular (lower
      jaw) infiltration injections of the first molar. The purpose of this prospective,
      randomized, double-blind, crossover study is to compare the degree of anesthesia obtained
      from the three solutions as a primary infiltration injection next to the mandibular first
      molar. The investigators also will record the pain of injection and postoperative pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Using a crossover design, 60 adult subjects will receive three injections consisting of a
      primary mandibular first molar infiltration of 1.8 mL of 4% articaine with 1:100,000
      epinephrine, 1.8 mL of 4% prilocaine with 1:200,000 epinephrine, and 1.8 mL of 4% lidocaine
      with 1:100,000 epinephrine in three separate appointments spaced at least one week apart.
      With the crossover design, 180 infiltrations will be given for the first molar and each
      subject will serve as his or her own control. Ninety infiltrations will be administered on
      the mandibular left side and ninety administered on the mandibular right side. The order of
      the three injections will be assigned randomly and the dentist and subject will be blinded
      about which anesthetic the subject is given. The anesthetics used in this study are not
      experimental. An electric pulp tester will be used to test the lower back teeth (molars and
      premolars) for anesthesia in 3-minute time intervals for a total of 60 minutes. The pain of
      injection and postoperative pain will be recorded in a survey. The data will be
      statistically analyzed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Successful Pulpal Anesthesia.</measure>
    <time_frame>60 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Two consecutive 80/80 readings (no patient response) during 60 minutes of testing with an electric pulp tester.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Anesthetic Effectiveness</condition>
  <arm_group>
    <arm_group_label>4% Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.8 mL of 4% lidocaine with 1:100,000 epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4% Articaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.8 mL of 4% articaine with 1:100,000 epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4% Prilocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.8 mL of 4% prilocaine with 1:200,000 epinephrine</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mandibular buccal Infiltration injection</intervention_name>
    <arm_group_label>4% Lidocaine</arm_group_label>
    <arm_group_label>4% Articaine</arm_group_label>
    <arm_group_label>4% Prilocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  between the ages of 18 and 65 years.

          -  in good health (ASA classification II or lower).

          -  able to provide informed consent.

        Exclusion Criteria:

          -  allergy to articaine, lidocaine or prilocaine.

          -  history of significant medical problems (ASA classification III or greater).

          -  depression (taking tri-cyclic antidepressant medications to control).

          -  have taken CNS depressants (including alcohol or any analgesic medications) within
             the last 48 hours prior to testing.

          -  lactating or pregnant.

          -  inability to give informed consent.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Ohio State University College of Dentistry, Postle Hall</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kanaa MD, Whitworth JM, Corbett IP, Meechan JG. Articaine buccal infiltration enhances the effectiveness of lidocaine inferior alveolar nerve block. Int Endod J. 2009 Mar;42(3):238-46. doi: 10.1111/j.1365-2591.2008.01507.x.</citation>
    <PMID>19228214</PMID>
  </reference>
  <reference>
    <citation>Kanaa MD, Whitworth JM, Corbett IP, Meechan JG. Articaine and lidocaine mandibular buccal infiltration anesthesia: a prospective randomized double-blind cross-over study. J Endod. 2006 Apr;32(4):296-8. Epub 2006 Feb 17.</citation>
    <PMID>16554198</PMID>
  </reference>
  <reference>
    <citation>Robertson D, Nusstein J, Reader A, Beck M, McCartney M. The anesthetic efficacy of articaine in buccal infiltration of mandibular posterior teeth. J Am Dent Assoc. 2007 Aug;138(8):1104-12.</citation>
    <PMID>17670879</PMID>
  </reference>
  <reference>
    <citation>Haase A, Reader A, Nusstein J, Beck M, Drum M. Comparing anesthetic efficacy of articaine versus lidocaine as a supplemental buccal infiltration of the mandibular first molar after an inferior alveolar nerve block. J Am Dent Assoc. 2008 Sep;139(9):1228-35. Erratum in: J Am Dent Assoc. 2008 Oct;139(10):1312.</citation>
    <PMID>18762633</PMID>
  </reference>
  <reference>
    <citation>Corbett IP, Kanaa MD, Whitworth JM, Meechan JG. Articaine infiltration for anesthesia of mandibular first molars. J Endod. 2008 May;34(5):514-8. doi: 10.1016/j.joen.2008.02.042.</citation>
    <PMID>18436027</PMID>
  </reference>
  <reference>
    <citation>Abdulwahab M, Boynes S, Moore P, Seifikar S, Al-Jazzaf A, Alshuraidah A, Zovko J, Close J. The efficacy of six local anesthetic formulations used for posterior mandibular buccal infiltration anesthesia. J Am Dent Assoc. 2009 Aug;140(8):1018-24.</citation>
    <PMID>19654255</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 7, 2013</lastchanged_date>
  <firstreceived_date>March 28, 2012</firstreceived_date>
  <firstreceived_results_date>June 24, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>John Nusstein</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>degree of pulpal anesthesia obtained</keyword>
  <keyword>primary infiltration in the lower first molar</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment at the College of Dentistry between May 2012 and December 2012.</recruitment_details>
      <pre_assignment_details>No exclusions. All subjects enrolled were utilized and assigned.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Subjects Receiving Injections</title>
          <description>All subjects received each of the three anesthetic injections.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>No difference.</population>
      <group_list>
        <group group_id="B1">
          <title>Subjects Receiving Injections</title>
          <description>All subjects received each of the three anesthetic injections.</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="60"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="60"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="25.8" spread="2.5"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="30"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="30"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="60"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Successful Pulpal Anesthesia.</title>
        <description>Two consecutive 80/80 readings (no patient response) during 60 minutes of testing with an electric pulp tester.</description>
        <time_frame>60 minutes</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>4% Articaine With 1:100,000 Epinephrine</title>
          </group>
          <group group_id="O2">
            <title>4% Lidocaine With 1:100,000 Epinephrine</title>
          </group>
          <group group_id="O3">
            <title>4% Prilocaine With 1:200,000 Epinephrine</title>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="60"/>
                  <measurement group_id="O2" value="60"/>
                  <measurement group_id="O3" value="60"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Successful Pulpal Anesthesia.</title>
            <description>Two consecutive 80/80 readings (no patient response) during 60 minutes of testing with an electric pulp tester.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Second Molar</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="37"/>
                  <measurement group_id="O2" value="27"/>
                  <measurement group_id="O3" value="22"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>First Molar</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="33"/>
                  <measurement group_id="O2" value="20"/>
                  <measurement group_id="O3" value="19"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Second Premolar</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="32"/>
                  <measurement group_id="O2" value="21"/>
                  <measurement group_id="O3" value="17"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>First Premolar</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="29"/>
                  <measurement group_id="O2" value="24"/>
                  <measurement group_id="O3" value="18"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>4% Articaine With 1:100,000 Epinephrine</title>
        </group>
        <group group_id="E2">
          <title>4% Lidocaine With 1:100,000 Epinephrine</title>
        </group>
        <group group_id="E3">
          <title>4% Prilocaine With 1:200,000 Epinephrine</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No adverse events.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. John Nusstein</name_or_title>
      <organization>The Ohio State University, Division of Endodontics</organization>
      <phone>614-292-9412</phone>
      <email>nusstein.1@osu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
